 provides methods of antagonizing, the 0HT-0A receptor, and therapeutic methods which are related to their effect on the 0HT-0A receptor. Such methods of treatment include, particularly, methods of alleviating the symptoms caused by withdrawal or partial withdrawal from the use of tobacco or of nicotine, comprising the administration to a patient in need of such treatment